Dr Andy Billinton
DA
Dr Andy Billinton
CSO
Rate
About
Dr. Andy Billinton has over 22 years of experience in drug discovery and early development in both large pharmaceutical companies and biotech. He joined Harness Therapeutics from Nodthera, where he focused on translational science. Previously, he held roles at MedImmune/AstraZeneca and GSK, leading neuroscience teams and projects up to Phase II. He also co-founded Transpharmation, a translational CRO.
Frequently asked
Who is Dr Andy Billinton?
Dr. Andy Billinton has over 22 years of experience in drug discovery and early development in both large pharmaceutical companies and biotech. He joined Harness Therapeutics from Nodthera, where he focused on translational science. Previously, he held roles at MedImmune/AstraZeneca and GSK, leading neuroscience teams and projects up to Phase II. He also co-founded Transpharmation, a translational…
What is Dr Andy Billinton's current role?
Dr Andy Billinton is currently CSO.
Comments
No comments yet. Be the first to share your take.
Profile
About Dr Andy Billinton
Dr Andy Billinton is CSO. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.